Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Su Hyun Lim, Gi Taek Yee, Dongwoo Khang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2529-2552
Open Access | Times Cited: 16
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 5
Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 3
Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review
Sonia Fathi‐karkan, Rabia Arshad, Abbas Rahdar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115676-115676
Closed Access | Times Cited: 39
Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
Xudong Cai, Calum J. Drummond, Jiali Zhai, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 12
The interaction between particles and vascular endothelium in blood flow
Xiaotong Li, Jiahui Zou, Zhongshan He, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115216-115216
Closed Access | Times Cited: 9
Angiopep-2-Functionalized Lipid Cubosomes for Blood–Brain Barrier Crossing and Glioblastoma Treatment
Xudong Cai, Ahmed Refaat, Poh‐Yi Gan, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12161-12174
Closed Access | Times Cited: 9
Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 1
Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Margarida Alberto, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2742-2742
Open Access | Times Cited: 30
Recent Advancement of Bio-Inspired Nanoparticles in Cancer Theragnostic
Divya Tripathi, Kasturee Hajra, Dipak Maity
Journal of Nanotheranostics (2023) Vol. 4, Iss. 3, pp. 299-322
Open Access | Times Cited: 16
Some Novel Therapies in Parkinson’s Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature
Anastasia Bougea
Biomedicines (2024) Vol. 12, Iss. 3, pp. 549-549
Open Access | Times Cited: 7
Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting
Alaa Alqudah, Alaa A. A. Aljabali, Omar Gammoh, et al.
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 6
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 678-678
Open Access | Times Cited: 15
Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease
Shalu Singh, Rahul Shukla
AAPS PharmSciTech (2023) Vol. 24, Iss. 7
Closed Access | Times Cited: 14
Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy
Jakleen Abujamai, Rukhsana Satar, Shakeel Ahmed Ansari
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 10, pp. 1251-1262
Closed Access | Times Cited: 5
Nanocarrier drug delivery system: promising platform for targeted depression therapy
Xiaoying Feng, Ping Jia, Dingding Zhang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders
Anglina Kisku, Ambresh Nishad, Saurabh Agrawal, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Exosomes: The endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders
Xuelin Tang, Yuxuan He, Jinchi Liu, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 239, pp. 113938-113938
Closed Access | Times Cited: 4
Biophysical translational paradigm of polymeric nanoparticle: Embarked advancement to brain tumor therapy
Shaikh Sheeran Naser, Abha R. Gupta, Anmol Choudhury, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117372-117372
Open Access | Times Cited: 4
Nanosystems for targeted drug Delivery: Innovations and challenges in overcoming the Blood-Brain barrier for neurodegenerative disease and cancer therapy
Nesa Rafati, Atefeh Zarepour, Ashkan Bigham, et al.
International Journal of Pharmaceutics (2024) Vol. 666, pp. 124800-124800
Closed Access | Times Cited: 4
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
pH-triggered small molecule nanodrugs self-assembled from tryptamine-cinnamaldehyde and fisetin for targeted sepsis-associated encephalopathy therapy
Ximing Deng, Jinyao Zhou, Wei Fang, et al.
Journal of Biomaterials Applications (2025)
Closed Access
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
Shuhan Liu, Haisong Li, Shiwen Xi, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1443-1490
Open Access
Page 1 - Next Page

Scroll to top